Investor Calendar powered by PrecisionIR

		Investor Calendar is powered by PrecisionIR, the leading webcaster of official investor relations events, and offers free access to live and archived corporate communications

Home

Calendar

Conferences

Roadshows

Forums

Alerts

Research

Support

Podcast

Adherex Tech - DO NOT USE (AHX.TO)	www.adherex.com

Enter your email address to receive alerts about this company

Help

October 2, 2002 - 10:30 AM Eastern
Adherex Announces Merger With Oxiquant

New Entity will Focus on Developing Pipeline of Anti-Cancer Compounds

Press Release
Transcript

Information contained in this webcast is current as of the date and time first presented. The use of pop-up blocking or firewall software may prevent you from accessing this webcast. Please temporarily disable any of these products you may have while attempting to access this event.

About The Company

Adherex Technologies Inc. is a biopharmaceutical company dedicated to the discovery and development of novel cancer therapeutics. We aim to be a leader in developing innovative treatments that address important unmet medical needs in cancer. We currently have multiple products in the clinical stage of development, including ADH-1 (Exherin™), eniluracil and sodium thiosulfate (STS). ADH-1, our lead biotechnology compound, selectively targets N-cadherin, a protein present on certain tumor cells and established blood vessels that feed solid tumors. Eniluracil, an oral dihydropyrimidine dehydrogenase (DPD) inhibitor, was previously under development by GlaxoSmithKline for oncology indications. STS, a drug from our specialty pharmaceuticals pipeline, protects against the disabling hearing loss that can often result from treatment with platinum-based chemotherapy drugs. With a diversified portfolio of unique preclinical and clinical-stage cancer compounds and a management team with expertise in identifying, developing and commercializing novel cancer therapeutics, Adherex is emerging as a pioneering oncology company. For more information, please visit our website at www.adherex.com

Market Assistant
SEC Filings Earnings Data Annual Report

Related Events (times are Eastern)	Show times in :


	Comments or questions? Click Here Privacy Statement Terms and Conditions ©2000-2013 PrecisionIR. All rights reserved.

	A part of PrecisionIR Group, www.PrecisionIR.com 9011 Arboretum Parkway, Suite 295, Richmond, VA 23236 2 Lansdowne Road, Croydon, CR9 2ER, UK (Registered in England No 2394368) Strandvägen 7A, 114 56 Stockholm, Sweden